Colorectal cancer screening in an expanding panorama of screening programmes

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 4, 2010, Pages 521-527

  Hoff, Geir ^a,b,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b TELEMARK HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Colorectal cancer; Screening

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HUMAN; OCCULT BLOOD TEST; REVIEW; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION;

EID: 77956565246     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.04.006     Document Type: Article

References (36)

1. World Health Organisation. Screening and early detection of cancer. http://www.who.int/cancer/detection/en/ [accessed 21.02.10].
2. J.M.G. Wilson, and G. Jungner Principles of practice of screening for disease 1968 World Health Organisation Geneva
3. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. www.screening.nhs. uk/criteria [accessed 21.02.10].
4. Advisory Committee on Cancer Prevention Recommendations on cancer screening in the European Union Eur J Cancer 36 2000 1473 1478
5. WHO: Screening for colorectal cancer. http://www.who.int/cancer/ detection/colorectalcancer/en/index.html [accessed 21.02.10].
6. K.L. Taylor, R. Shelby, E. Gelmann, and C. McGuire Quality of life and trial adgherence among participants in the prostate, lung, colorectal and ovarian cancer screening trial JNCI 96 2004 1083 1094
7. O. Kronborg, O.D. Jørgensen, C. Fenger, and M. Rasmussen Randomized study of biennial screening with a faecal occult blood test: results after nine rounds Scand J Gastroenterol 39 2004 846 851
8. J.S. Mandel, T.R. Church, J.H. Bond, F. Ederer, M.S. Geisser, and S.J. Mongin The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 2000 1603 1607
9. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
10. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
11. UK flexible sigmoidoscopy screening trial investigators Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomized trial Lancet 359 2002 1291 1300
12. N. Segnan, C. Senore, B. Andreoni, H. Aste, L. Bonelli, and C. Crosta Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE J Natl Ca Inst 94 2002 1763 1772
13. G. Hoff, T. Grotmol, E. Skovlund, and M. Bretthauer Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial Br Med J 338 2009 b1846
14. The Nordic-European Initiative on Colorectal Cancer-NordICC. http://www.kreftregisteret.no/nordicc [accessed 21.02.10].
15. O. Olsen, and P.C. Gøtsche Cochrane review on screening for breast cancer with mammography Lancet 358 2001 1340 1342
16. V.P. Jackson Screening mammography: Controversies and headlines Radiology 225 2002 323 326
17. N. Malila, T. Oivanen, O. Malminiemi, and M. Hakama Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design BMJ 337 2008 a2261
18. G.S. Dulai, M.M. Farmer, P.A. Ganz, C.A. Bernaards, K. Qi, and A.J. Dietrich Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting Cancer 100 2004 1843 1852
19. P. Moayyedi, and E. Achkar Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data Am J Gastroenterol 101 2006 380 384
20. A. Tufts German patients escape financial penalties for not following their doctor's advice Br Med J 336 2008 65
21. L. Hol, J.A. Wilscut, M. vanBallegooijen, A.J. van Vuuren, H. van der Valk, and JCIY Reijerink Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 2009 1103 1110
22. L.G. Van Rossum, A.F. van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and H.H. van Krieken Random comparison of Guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
23. N.N. Baxter, M.A. Goldwasser, L.F. Paszat, R. Saskin, D.R. Urbach, and L. Rabeneck Association of colonoscopy and death from colorectal cancer Ann Intern Med 150 1 2009 Jan 6 1 8 [Epub 2008 Dec 15]
24. J. Cuzick, F.H. Cafferty, R. Edwards, H. Møller, and S.W. Duffy Surrogate end-points for cancer screening trials: general principles and an illustration using the UK flexible sigmoidoscopy screening trial J Med Screen 14 2007 178 185
25. P. Piedbois, and M. Buyse Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments Curr Opin Oncol 20 2008 466 471
26. Commission on Chronic Illness Chronic illness in the United States Prevention of chronic illness vol. 1 1957 Harvard University Press Cambridge, Mass
27. D. Shrag The price tag on progress-chemotherapy for colorectal cancer N Engl J Med 351 2004 317 319
28. A. Sieg, and H. Brenner Cost-saving analysis of screening colonoscopy in Germany Z Gastroenterol 45 2007 945 951
29. L. Hol, M.E. van Leerdam, M. van Ballegooijen, A.J. van Vuuren, H. van Dekken, and JCIY Reijerink Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoiodoscopy Gut 59 2010 62 68
30. H. Brenner, M. Hoffmeister, V. Arndt, C. Stegmaier, L. Altenhofen, and U. Haug Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study JNCI 102 2010 89 95
31. G. Gondal, T. Grotmol, B. Hofstad, M. Bretthauer, T.J. Eide, and G. Hoff The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study. Baseline findings and implications for clinical work-up in age groups 50-64 years Scand J Gastroenterol 38 2003 635 642
32. D.A. Lieberman, D.G. Weiss, and for the Veterans Affairs Cooperative Study Group One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 345 2001 555 560
33. A.G. Zauber, I. Lansdorp, A.B. Knudsen, J. Wilschut, M. van Ballegooijen, and K.M. Kuntz Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force Ann Int Med 149 2008 659 669
34. E. Thiis-Evensen, G.S. Hoff, J. Sauar, F. Langmark, B.M. Majak, and M.H. Vatn Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer Scand J Gastroenterol 34 1999 414 420
35. M. Corbett, S.L. Chambers, B. Shadbolt, L.C. Hillman, and D. Taupin Colonoscopy screening for colorectal cancer: the outcomes of two recruitment methods MJA 181 2004 423 427
36. W.S. Atkin, R. Edwards, I. Kralj-Hans, K. Wooldrage, A.R. Hart, and J.M.A. Northover Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 2010 1624 1633